WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

ANTICHOLINERGIC DRUG THERAPY IN PATIENTS WITH OVER ACTIVE BLADDER CONDITION

Ashmi Salam*, Rani Manju, Pheba Susan Thomas and Dr. Santhosh M. Mathews

ABSTRACT

Many peoples have symptoms of overactive bladder. A person with overactive bladder syndrome feels a very strong urge to pass urine. Other common problems are a feeling of urinate often during the day or night, or both. This problem seems to be caused by an overactive bladder muscle, and it becomes more common with ageing. Treatments are only the conservative measures, such as drugs. Anticholinergic drugs can reduce the overactivity of the bladder muscle and the feeling of urgency. The review found that there are several anticholinergic drugs prescribed for patient with overactive bladder symptoms. The two most prescribed drugs are oxybutynin and tolterodine. These two drugs have similar effects but, those who taking oxybutynin were more likely to withdraw the drug because of adverse effects, mainly dry mouth. However, both drugs can give dry mouth and this problem is less likely if an extended- release formulation of either drug is used. Two newer drugs are Solifenacin and Fesoterodine. Solifenacin has a better effect and less risk of dry mouth compared to tolterodine. Fesoterodine has a better effect than extended release tolterodine but withdrawal of drug due to adverse effects mainly dry mouth.

Keywords: Over active bladder, signs and symptoms, anticholinergic drugs, detrusor overactivity, adverse effect.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More